Literature DB >> 8755583

Apoptosis and APC in colorectal tumorigenesis.

P J Morin1, B Vogelstein, K W Kinzler.   

Abstract

Tumors result from disruptions in the homeostatic mechanisms that regulate cell birth and cell death. In colon cancer, one of the earliest manifestation of this imbalance is the formation of polyps, caused by somatic and inherited mutations of the adenomatous polyposis coli (APC) tumor suppressor gene in both humans and mice. While the importance of APC in tumorigenesis is well documented, how it functions to prevent tumors remains a mystery. Using a novel inducible expression system, we show that expression of APC in human colorectal cancer cells containing endogenous inactive APC alleles results in a substantial diminution of cell growth. Further evaluation demonstrated that this was due to the induction of cell death through apoptosis. These results suggest that apoptosis plays a role not only in advanced tumors but also at the very earliest stages of neoplasia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755583      PMCID: PMC38855          DOI: 10.1073/pnas.93.15.7950

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Association of the APC gene product with beta-catenin.

Authors:  B Rubinfeld; B Souza; I Albert; O Müller; S H Chamberlain; F R Masiarz; S Munemitsu; P Polakis
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

2.  Hyperinducible human metallothionein promoter with a low level basal activity.

Authors:  S S Makarov; C Jonat; S Haskill
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

3.  Wild-type but not mutant APC associates with the microtubule cytoskeleton.

Authors:  K J Smith; D B Levy; P Maupin; T D Pollard; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

4.  The APC gene product associates with microtubules in vivo and promotes their assembly in vitro.

Authors:  S Munemitsu; B Souza; O Müller; I Albert; B Rubinfeld; P Polakis
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

Review 5.  From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion.

Authors:  R Kemler
Journal:  Trends Genet       Date:  1993-09       Impact factor: 11.639

6.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.

Authors:  R Fodde; W Edelmann; K Yang; C van Leeuwen; C Carlson; B Renault; C Breukel; E Alt; M Lipkin; P M Khan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Association of the APC tumor suppressor protein with catenins.

Authors:  L K Su; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1993-12-10       Impact factor: 47.728

8.  Molecular determinants of dysplasia in colorectal lesions.

Authors:  J Jen; S M Powell; N Papadopoulos; K J Smith; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

9.  Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.

Authors:  A J Smith; H S Stern; M Penner; K Hay; A Mitri; B V Bapat; S Gallinger
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

10.  Association between wild type and mutant APC gene products.

Authors:  L K Su; K A Johnson; K J Smith; D E Hill; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

View more
  124 in total

Review 1.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.

Authors:  F T Kolligs; B Kolligs; K M Hajra; G Hu; M Tani; K R Cho; E R Fearon
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

3.  Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators.

Authors:  K Kim; K M Pang; M Evans; E D Hay
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

4.  TCF-3, 4 protein expression correlates with beta-catenin expression in MSS and MSI-H colorectal cancer from HNPCC patients but not in sporadic colorectal cancers.

Authors:  Peter Balaz; Jens Plaschke; Stefan Krüger; Heike Görgens; Hans K Schackert
Journal:  Int J Colorectal Dis       Date:  2010-06-08       Impact factor: 2.571

5.  Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis.

Authors:  J Rak; Y Mitsuhashi; C Sheehan; J K Krestow; V A Florenes; J Filmus; R S Kerbel
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 6.  [Carcinogenesis and hereditart colon cancers].

Authors:  F Kullmann
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

7.  The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.

Authors:  Songbai Lin; Sei-Jung Lee; Hyunsuk Shim; Jerold Chun; C Chris Yun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

8.  Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer.

Authors:  Nathaniel S Rial; Gwendal Lazennec; Anil R Prasad; Robert S Krouse; Peter Lance; Eugene W Gerner
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

9.  Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2.

Authors:  Hiroshi Nishihara; Shinae Kizaka-Kondoh; Paul A Insel; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-01       Impact factor: 11.205

10.  Reduction of intestinal neoplasia with adenomatous polyposis coli gene replacement and COX-2 inhibition is additive.

Authors:  John I Lew; Yuee Guo; Richard K Kim; Lisa Vargish; Fabrizio Michelassi; Richard B Arenas
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.